Welsh R M, Lampert P W, Oldstone M B
J Infect Dis. 1977 Sep;136(3):391-9. doi: 10.1093/infdis/136.3.391.
Defective-interfering (DI) lymphocytic choriomeningitis virus (LCMV) prevented disease in the central nervous system produced by standard LCMV. Standard LCMV injected into Lewis rats two days after birth produced a disorder distinguishable clinically by weight loss and ataxia and histologically by infiltration of mononuclear cells and necrosis of the cerebellum. Concurrent injection of DI LCMV with standard LCMV prevented the disease and markedly reduced the synthesis of standard LCMV and of viral antigens in the brain. Because inhibition of viral synthesis occurred early (day 3) after infection and because no interferon activity could be demonstrated, it was concluded that the interference effect was likely due to DI virus-mediated homologous interference. Other experiments showed that DI LCMV blocked viral antigen synthesis in culture. The curtailed production of viral antigens and cytolytic standard virus by DI virus may play a role in control of acute and persistent viral infections.
缺陷干扰(DI)淋巴细胞性脉络丛脑膜炎病毒(LCMV)可预防标准LCMV在中枢神经系统引发的疾病。出生两天后注射到Lewis大鼠体内的标准LCMV会引发一种疾病,临床上可通过体重减轻和共济失调区分,组织学上可通过单核细胞浸润和小脑坏死区分。将DI LCMV与标准LCMV同时注射可预防该疾病,并显著减少标准LCMV及其病毒抗原在脑中的合成。由于病毒合成的抑制在感染后早期(第3天)就已发生,且未检测到干扰素活性,因此得出结论,干扰作用可能是由DI病毒介导的同源干扰引起的。其他实验表明,DI LCMV可阻断培养物中病毒抗原的合成。DI病毒导致病毒抗原和溶细胞性标准病毒的产生减少,这可能在控制急性和持续性病毒感染中发挥作用。